Company: DVAX
Filing Date: 2025-11-05
Form Type: 8-K
Source: 0001628280-25-049515
Chunk: 1

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-11-05
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibit is furnished herewith:

  99.1      Press release dated November 5, 2025 titled "Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program."  
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                            Dynavax Technologies Corporation  
  Date:      November 5, 2025      By:      /s/ Kelly MacDonald               
                                            Kelly MacDonald